Literature DB >> 23775699

Searching for prostate cancer stem cells: markers and methods.

Benjamin Sharpe1, Mark Beresford, Rebecca Bowen, John Mitchard, Andrew D Chalmers.   

Abstract

The cancer stem cell hypothesis postulates that a single stem-like cancer cell is able to produce all cancer cell types found in a tumor. These cells are also thought to be the causative agents of relapse following therapy. In order to confirm the importance of cancer stem cells in tumor formation and patient prognosis, their role in prostate cancer must be comprehensively studied. This review describes current methods and markers for isolating and characterizing prostate cancer stem cells, including assays for self-renewal, multipotency and resistance to therapy. In particular the advantages and limitations of these approaches are analyzed. The review will also examine novel methods for studying the lineage of cancer stem cells in vivo using transgenic mouse models. These lineage tracing approaches have significant advantages and, if a number of challenges can be addressed, offer great potential for understanding the significance of cancer stem cells in human prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23775699     DOI: 10.1007/s12015-013-9453-4

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  71 in total

1.  Brief report: a bioassay to identify primary human prostate cancer repopulating cells.

Authors:  Roxanne Toivanen; David M Berman; Hong Wang; John Pedersen; Mark Frydenberg; Alan K Meeker; Stuart J Ellem; Gail P Risbridger; Renea A Taylor
Journal:  Stem Cells       Date:  2011-08       Impact factor: 6.277

2.  Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer.

Authors:  Markus Germann; Antoinette Wetterwald; Natalia Guzmán-Ramirez; Gabri van der Pluijm; Zoran Culig; Marco G Cecchini; Elizabeth D Williams; George N Thalmann
Journal:  Stem Cells       Date:  2012-06       Impact factor: 6.277

Review 3.  Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization.

Authors:  Virginia Tirino; Vincenzo Desiderio; Francesca Paino; Alfredo De Rosa; Federica Papaccio; Marcella La Noce; Luigi Laino; Francesco De Francesco; Gianpaolo Papaccio
Journal:  FASEB J       Date:  2012-09-28       Impact factor: 5.191

4.  Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity.

Authors:  Gong Zhang; Lei Ma; You-Ke Xie; Xiao-Bo Miao; Chuan Jin
Journal:  Mol Med Rep       Date:  2012-06-08       Impact factor: 2.952

5.  Sphere formation reverses the metastatic and cancer stem cell phenotype of the murine mammary tumour 4T1, independently of the putative cancer stem cell marker Sca-1.

Authors:  Heli Matilainen; Xiao-Wen Yu; Ching-Wen Tang; Michael V Berridge; Melanie J McConnell
Journal:  Cancer Lett       Date:  2012-03-27       Impact factor: 8.679

6.  Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties.

Authors:  Linlin Zhang; Min Jiao; Lei Li; Dapeng Wu; Kaijie Wu; Xiang Li; Guodong Zhu; Qiang Dang; Xinyang Wang; Jer-Tsong Hsieh; Dalin He
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-12       Impact factor: 4.553

7.  Eyes wide open: a critical review of sphere-formation as an assay for stem cells.

Authors:  Erika Pastrana; Violeta Silva-Vargas; Fiona Doetsch
Journal:  Cell Stem Cell       Date:  2011-05-06       Impact factor: 24.633

8.  Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

Authors:  Arnout G Schepers; Hugo J Snippert; Daniel E Stange; Maaike van den Born; Johan H van Es; Marc van de Wetering; Hans Clevers
Journal:  Science       Date:  2012-08-01       Impact factor: 47.728

9.  Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

Authors:  A F Olumi; G D Grossfeld; S W Hayward; P R Carroll; T D Tlsty; G R Cunha
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

10.  ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.

Authors:  Ting Li; Yun Su; Yuping Mei; Qixin Leng; Bingjie Leng; Zhenqiu Liu; Sanford A Stass; Feng Jiang
Journal:  Lab Invest       Date:  2009-12-14       Impact factor: 5.662

View more
  23 in total

Review 1.  Common stemness regulators of embryonic and cancer stem cells.

Authors:  Christiana Hadjimichael; Konstantina Chanoumidou; Natalia Papadopoulou; Panagiota Arampatzi; Joseph Papamatheakis; Androniki Kretsovali
Journal:  World J Stem Cells       Date:  2015-10-26       Impact factor: 5.326

2.  Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas.

Authors:  Francesca Boscolo Sesillo; Alessandra Sacco
Journal:  J Vis Exp       Date:  2019-09-13       Impact factor: 1.355

Review 3.  Gastric cancer stem cells: evidence, potential markers, and clinical implications.

Authors:  Daniel Brungs; Morteza Aghmesheh; Kara L Vine; Therese M Becker; Martin G Carolan; Marie Ranson
Journal:  J Gastroenterol       Date:  2015-10-01       Impact factor: 7.527

Review 4.  Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer.

Authors:  Clara H Lee; Ann M Decker; Frank C Cackowski; Russell S Taichman
Journal:  Cell Biol Toxicol       Date:  2019-06-27       Impact factor: 6.691

Review 5.  Interaction between prostate cancer stem cells and bone microenvironment regulates prostate cancer bone metastasis and treatment resistance.

Authors:  Lu Yao; Xiangyu Zhang
Journal:  J Cancer       Date:  2022-06-13       Impact factor: 4.478

6.  Novel piRNA MW557525 regulates the growth of Piwil2-iCSCs and maintains their stem cell pluripotency.

Authors:  Liming Jin; Zhaoxia Zhang; Zhang Wang; Xiaojun Tan; Zhaoying Wang; Lianju Shen; Chunlan Long; Guanghui Wei; Dawei He
Journal:  Mol Biol Rep       Date:  2022-04-11       Impact factor: 2.742

Review 7.  An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy.

Authors:  R G Bristow; A Berlin; A Dal Pra
Journal:  Br J Radiol       Date:  2014-02-03       Impact factor: 3.039

Review 8.  Metformin and prostate cancer stem cells: a novel therapeutic target.

Authors:  M J Mayer; L H Klotz; V Venkateswaran
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-07-28       Impact factor: 5.554

9.  RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance.

Authors:  David T Miyamoto; Yu Zheng; Ben S Wittner; Richard J Lee; Huili Zhu; Katherine T Broderick; Rushil Desai; Douglas B Fox; Brian W Brannigan; Julie Trautwein; Kshitij S Arora; Niyati Desai; Douglas M Dahl; Lecia V Sequist; Matthew R Smith; Ravi Kapur; Chin-Lee Wu; Toshi Shioda; Sridhar Ramaswamy; David T Ting; Mehmet Toner; Shyamala Maheswaran; Daniel A Haber
Journal:  Science       Date:  2015-09-18       Impact factor: 47.728

10.  Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells.

Authors:  Sabrina Labsch; Li Liu; Nathalie Bauer; Yiyao Zhang; Ewa Aleksandrowicz; Jury Gladkich; Frank Schönsiegel; Ingrid Herr
Journal:  Int J Oncol       Date:  2014-03-10       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.